Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Sep 30, 2025 | FY 2024Sep 30, 2024 |
|---|---|---|
| Total Revenue | 0.00 | -- |
| Operating Revenue | 0.00 | -- |
| Selling General And Administration | 1.0M | -- |
| General And Administrative Expense | 1.0M | -- |
| Research And Development | 1,073 | -- |
| Operating Expense | 1.0M | -- |
| Operating Income | -1.0M | -- |
| EBIT | -1.0M | -- |
| Other Income Expense | -189,832 | -- |
| Other Non Operating Income Expenses | 290,204 | -- |
| Special Income Charges | -482,036 | -- |
| Write Off | 470,119 | -- |
| Gain On Sale Of Security | 2,000 | -- |
| Pretax Income | -1.2M | -- |
| Tax Effect Of Unusual Items | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -1.2M | -- |
| Net Income From Continuing Operation Net Minority Interest | -1.2M | -- |
| Net Income Including Noncontrolling Interests | -1.2M | -- |
| Net Income Common Stockholders | -1.2M | -- |
| Net Income | -1.2M | -- |
| EBITDA | -1.0M | -- |
| Normalized EBITDA | -565,713 | -- |
| Total Unusual Items | -480,036 | -- |
| Total Unusual Items Excluding Goodwill | -480,036 | -- |
| Tax Rate For Calcs | 0.00 | -- |
| Normalized Income | -755,545 | -- |
| Diluted NI Availto Com Stockholders | -1.2M | -- |
| Impairment Of Capital Assets | 11,917 | -- |
| Net Income Continuous Operations | -1.2M | -- |
| Other Gand A | 646,431 | -- |
| Salaries And Wages | 365,520 | -- |
| Selling And Marketing Expense | 32,725 | -- |
| Total Expenses | 1.0M | -- |
| Line Item | FY 2025Sep 30, 2025 | FY 2024Sep 30, 2024 |
|---|---|---|
| Cash And Cash Equivalents | 1.1M | 70,089 |
| Cash Cash Equivalents And Short Term Investments | 1.3M | 70,089 |
| Cash Equivalents | 29,267 | -- |
| Cash Financial | 1.1M | 70,089 |
| Other Short Term Investments | 138,000 | 0.00 |
| Receivables | 109,655 | 425.00 |
| Prepaid Assets | 935,551 | 745,218 |
| Current Assets | 2.3M | 815,732 |
| Net PPE | 8.2M | 6.9M |
| Total Non Current Assets | 8.2M | 6.9M |
| Total Assets | 10.5M | 7.7M |
| Accounts Payable | 350,943 | 5,234 |
| Payables | 350,943 | 5,234 |
| Payables And Accrued Expenses | 523,612 | 5,234 |
| Current Accrued Expenses | 172,669 | 0.00 |
| Other Current Liabilities | 20,562 | -- |
| Current Liabilities | 544,174 | 5,234 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 544,174 | 5,234 |
| Common Stock | 10.3M | 7.2M |
| Capital Stock | 10.3M | 7.2M |
| Retained Earnings | -1.9M | -707,275 |
| Gains Losses Not Affecting Retained Earnings | 1.6M | 1.3M |
| Common Stock Equity | 10.0M | 7.7M |
| Stockholders Equity | 10.0M | 7.7M |
| Total Equity Gross Minority Interest | 10.0M | 7.7M |
| Total Capitalization | 10.0M | 7.7M |
| Net Tangible Assets | 10.0M | 7.7M |
| Tangible Book Value | 10.0M | 7.7M |
| Working Capital | 1.8M | 810,498 |
| Invested Capital | 10.0M | 7.7M |
| Share Issued | 78.0M | 63.3M |
| Ordinary Shares Number | 78.0M | 63.3M |
| Taxes Receivable | 109,655 | 425.00 |
| Line Item | FY 2025Sep 30, 2025 | FY 2024Sep 30, 2024 |
|---|---|---|
| Operating Cash Flow | -954,385 | -- |
| Cash Flow From Continuing Operating Activities | -954,385 | -- |
| Stock Based Compensation | 317,023 | -- |
| Deferred Tax | -259,438 | -- |
| Deferred Income Tax | -259,438 | -- |
| Change In Working Capital | -313,092 | -- |
| Change In Receivables | -109,230 | -- |
| Change In Payables And Accrued Expense | 456,590 | -- |
| Other Non Cash Items | 56,667 | -- |
| Capital Expenditure | -1.4M | -- |
| Purchase Of PPE | -1.4M | -- |
| Net PPE Purchase And Sale | -1.4M | -- |
| Investing Cash Flow | -1.4M | -- |
| Cash Flow From Continuing Investing Activities | -1.4M | -- |
| Issuance Of Capital Stock | 3.5M | -- |
| Net Common Stock Issuance | 3.5M | -- |
| Financing Cash Flow | 3.4M | -- |
| Cash Flow From Continuing Financing Activities | 3.4M | -- |
| Changes In Cash | 1.1M | -- |
| Beginning Cash Position | 70,089 | -- |
| End Cash Position | 1.1M | -- |
| Free Cash Flow | -2.4M | -- |
| Asset Impairment Charge | 482,036 | -- |
| Change In Prepaid Assets | -660,452 | -- |
| Common Stock Issuance | 3.5M | -- |
| Net Income From Continuing Operations | -1.2M | -- |
| Net Other Financing Charges | -115,795 | -- |
| Sale Of PPE | 50,000 | -- |
| Unrealized Gain Loss On Investment Securities | -2,000 | -- |